Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-14-001036
Accepted
2014-04-18 00:15:11
Documents
1
Effectiveness Date
2014-04-17
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 600
  Complete submission text file 9999999995-14-001036.txt   1778
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-194768 | Film No.: 14771335
SIC: 6770 Blank Checks